UNSPSC 51422104: Diflucortolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28F2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K253365DXI, chemically known as 6alpha,9-difluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione but generally known as diflucortolone, which bears US NIH Compound Identifier 17455. European Medicines Agency schedules Diflucortolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07128MIG.

UNSPSC 51422104 Diflucortolone is a Commodity code, but the recent state and local procurement activity tagged under it does not align with the code's pharmaceutical scope. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually—neither of which is diflucortolone (a topical corticosteroid). The mismatch suggests either a data-tagging error in the solicitation or a misclassification in the source. The county's procurement specifies quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor bids. Bidders must submit electronically, provide unit costs per line item, hold drug-free workplace certification and E-Verify compliance, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract term is two years with an optional one-year renewal, and vendors are subject to a three-month probationary period. FEMA funding introduces additional compliance requirements, including adherence to the Clean Air Act and Federal Water Pollution Control Act.

The single recent opportunity reflects Seminole County as the issuing body, a county health authority rather than a state department, school district, or transit system. The response deadline for the county's IFB was July 26, 2023 (a historical date relative to the June 30, 2026 posting marker, likely a data-entry error in the source). Geographic activity is limited to Florida based on available records. Without additional recent opportunities aligned to the diflucortolone code's actual scope—pharmaceutical topical products for state and local health systems, clinics, or emergency services—this code shows minimal relevant procurement activity in the current state and local market.